CLINICAL_TRIALS
trial_result
· 2016-02-17
Clinical Trial Update: A Phase 1 Study of Ertugliflozin in Healthy Male Participants (MK-8835-020) [Phase 1]
Summary
Phase 1 study of ertugliflozin in healthy male participants completed; results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2016-02-17